EMR files Form 144 to sell 4,773 shares valued at 640,000
EMR has a planned insider sale under Rule 144.
Rhea-AI Filing Summary
EMR has a planned insider sale under Rule 144. The notice covers the proposed sale of 4,773 shares of common stock, with an aggregate market value of 640,000. These shares are part of 1,500,000 shares outstanding and are to be sold through Merrill Lynch on or about 12/01/2025 on the NYSE. The seller originally acquired the shares on 02/01/2016 as a stock award from the issuer, described as compensation.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does EMR's latest Form 144 filing disclose?
The Form 144 filing for EMR discloses a planned sale of 4,773 shares of common stock with an aggregate market value of 640,000 through Merrill Lynch on or about 12/01/2025.
What does the Form 144 representation say about material information for EMR?
The person for whose account the EMR securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.